Based in Zurich, Switzerland, LifeMatrix Technologies AG is a pre-revenue, high-tech startup company spun out of the University of Zurich.
The LifeMatrix team combines world-leading scientists in cardiovascular tissue engineering with in depth industrial experience in the field of implants. LifeMatrix is currently part of the startup accelerator Wyss Zurich.
Active in the field of biomimetic implants, LifeMatrix develops human cell derived, off-the-shelf available tissue engineered implants, which transform into living tissue after implantation and have the capacity to grow and regenerate with the patient.
The award winning technology is the result of multiple national and international research grants and is backed by >20 years of research with >100 peer-reviewed publications.
Extensive preclinical (animal) studies demonstrated safety and efficacy and allow the technology to be translated in to clinical application.
If you’d like to request more information about our next-generation implants then get in touch with our team.
© 2019 LifeMatrix™ Back to top